#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Development of a Standardized Screening Rule for Tuberculosis in People Living with HIV in Resource-Constrained Settings: Individual Participant Data Meta-analysis of Observational Studies


Background:
The World Health Organization recommends the screening of all people living with HIV for tuberculosis (TB) disease, followed by TB treatment, or isoniazid preventive therapy (IPT) when TB is excluded. However, the difficulty of reliably excluding TB disease has severely limited TB screening and IPT uptake in resource-limited settings. We conducted an individual participant data meta-analysis of primary studies, aiming to identify a sensitive TB screening rule.

Methods and Findings:
We identified 12 studies that had systematically collected sputum specimens regardless of signs or symptoms, at least one mycobacterial culture, clinical symptoms, and HIV and TB disease status. Bivariate random-effects meta-analysis and the hierarchical summary relative operating characteristic curves were used to evaluate the screening performance of all combinations of variables of interest. TB disease was diagnosed in 557 (5.8%) of 9,626 people living with HIV. The primary analysis included 8,148 people living with HIV who could be evaluated on five symptoms from nine of the 12 studies. The median age was 34 years. The best performing rule was the presence of any one of: current cough (any duration), fever, night sweats, or weight loss. The overall sensitivity of this rule was 78.9% (95% confidence interval [CI] 58.3%–90.9%) and specificity was 49.6% (95% CI 29.2%–70.1%). Its sensitivity increased to 90.1% (95% CI 76.3%–96.2%) among participants selected from clinical settings and to 88.0% (95% CI 76.1%–94.4%) among those who were not previously screened for TB. Negative predictive value was 97.7% (95% CI 97.4%–98.0%) and 90.0% (95% CI 88.6%–91.3%) at 5% and 20% prevalence of TB among people living with HIV, respectively. Abnormal chest radiographic findings increased the sensitivity of the rule by 11.7% (90.6% versus 78.9%) with a reduction of specificity by 10.7% (49.6% versus 38.9%).

Conclusions:
Absence of all of current cough, fever, night sweats, and weight loss can identify a subset of people living with HIV who have a very low probability of having TB disease. A simplified screening rule using any one of these symptoms can be used in resource-constrained settings to identify people living with HIV in need of further diagnostic assessment for TB. Use of this algorithm should result in earlier TB diagnosis and treatment, and should allow for substantial scale-up of IPT.

: Please see later in the article for the Editors' Summary


Vyšlo v časopise: Development of a Standardized Screening Rule for Tuberculosis in People Living with HIV in Resource-Constrained Settings: Individual Participant Data Meta-analysis of Observational Studies. PLoS Med 8(1): e32767. doi:10.1371/journal.pmed.1000391
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1000391

Souhrn

Background:
The World Health Organization recommends the screening of all people living with HIV for tuberculosis (TB) disease, followed by TB treatment, or isoniazid preventive therapy (IPT) when TB is excluded. However, the difficulty of reliably excluding TB disease has severely limited TB screening and IPT uptake in resource-limited settings. We conducted an individual participant data meta-analysis of primary studies, aiming to identify a sensitive TB screening rule.

Methods and Findings:
We identified 12 studies that had systematically collected sputum specimens regardless of signs or symptoms, at least one mycobacterial culture, clinical symptoms, and HIV and TB disease status. Bivariate random-effects meta-analysis and the hierarchical summary relative operating characteristic curves were used to evaluate the screening performance of all combinations of variables of interest. TB disease was diagnosed in 557 (5.8%) of 9,626 people living with HIV. The primary analysis included 8,148 people living with HIV who could be evaluated on five symptoms from nine of the 12 studies. The median age was 34 years. The best performing rule was the presence of any one of: current cough (any duration), fever, night sweats, or weight loss. The overall sensitivity of this rule was 78.9% (95% confidence interval [CI] 58.3%–90.9%) and specificity was 49.6% (95% CI 29.2%–70.1%). Its sensitivity increased to 90.1% (95% CI 76.3%–96.2%) among participants selected from clinical settings and to 88.0% (95% CI 76.1%–94.4%) among those who were not previously screened for TB. Negative predictive value was 97.7% (95% CI 97.4%–98.0%) and 90.0% (95% CI 88.6%–91.3%) at 5% and 20% prevalence of TB among people living with HIV, respectively. Abnormal chest radiographic findings increased the sensitivity of the rule by 11.7% (90.6% versus 78.9%) with a reduction of specificity by 10.7% (49.6% versus 38.9%).

Conclusions:
Absence of all of current cough, fever, night sweats, and weight loss can identify a subset of people living with HIV who have a very low probability of having TB disease. A simplified screening rule using any one of these symptoms can be used in resource-constrained settings to identify people living with HIV in need of further diagnostic assessment for TB. Use of this algorithm should result in earlier TB diagnosis and treatment, and should allow for substantial scale-up of IPT.

: Please see later in the article for the Editors' Summary


Zdroje

1. GetahunH

GunnebergC

GranichR

NunnP

2010 HIV infection-associated tuberculosis: the epidemiology and the response. Clin Infect Dis 50 S201 207

2. SonnenbergP

GlynnJR

FieldingK

MurrayJ

Godfrey-FaussettP

2005 How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners. J Infect Dis 191 150 158

3. HavlirDV

GetahunH

SanneI

NunnP

2008 Opportunities and challenges for HIV care in overlapping HIV and TB epidemics. JAMA 300 423 430

4. MukadiYD

WiktorSZ

CoulibalyIM

CoulibalyD

MbengueA

1997 Impact of HIV infection on the development, clinical presentation, and outcome of tuberculosis among children in Abidjan, Cote d'Ivoire. Aids 11 1151 1158

5. ManosuthiW

ChottanapandS

ThongyenS

ChaovavanichA

SungkanuparphS

2006 Survival rate and risk factors of mortality among HIV/tuberculosis-coinfected patients with and without antiretroviral therapy. J Acquir Immune Defic Syndr 43 42 46

6. LawnSD

MyerL

OrrellC

BekkerLG

WoodR

2005 Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design. Aids 19 2141 2148

7. GandhiNR

MollA

SturmAW

PawinskiR

GovenderT

2006 Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 368 1575 1580

8. WellsCD

CegielskiJP

NelsonLJ

LasersonKF

HoltzTH

2007 HIV infection and multidrug-resistant tuberculosis: the perfect storm. J Infect Dis 196 Suppl 1 S86 107

9. BadriM

WilsonD

WoodR

2002 Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study. Lancet 359 2059 2064

10. MirandaA

MorganM

JamalL

LasersonK

BarreiraD

2007 Impact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995-2001. PLoS ONE 2 e826 doi:10.1371/journal.pone.0000826

11. LawnSD

MyerL

BekkerLG

WoodR

2006 Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control. Aids 20 1605 1612

12. BurgessAL

FitzgeraldDW

SevereP

JosephP

NoelE

2001 Integration of tuberculosis screening at an HIV voluntary counselling and testing centre in Haiti. Aids 15 1875 1879

13. AkoloC

AdetifaI

ShepperdS

VolminkJ

2010 Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev CD000171

14. WHO 2004 Interim policy on collaborative TB/HIV activities, World Health Organization. Geneva: WHO. WHO/HTM/TB/2004.330 WHO/HTM/HIV/2004.1. 2004

15. WHO 2010 Global tuberculosis control report: World Health Organization. Geneva: WHO. WHO/HTM/TB/ 2010.7

16. ReidMJ

ShahNS

2009 Approaches to tuberculosis screening and diagnosis in people with HIV in resource-limited settings. Lancet Infect Dis 9 173 184

17. GetahunH

HarringtonM

O'BrienR

NunnP

2007 Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes. Lancet 369 2042 2049

18. AylesH

SchaapA

NotaA

SismanidisC

TembweR

2009 Prevalence of tuberculosis, HIV and respiratory symptoms in two Zambian communities: implications for tuberculosis control in the era of HIV. PLoS One 4 e5602 doi:10.1371/journal.pone.0005602

19. CorbettEL

ZezaiA

CheungYB

BandasonT

DauyaE

2010 Provider-initiated symptom screening for tuberculosis in Zimbabwe: diagnostic value and the effect of HIV status. Bull World Health Organ 88 13 21

20. CainKP

McCarthyKD

HeiligCM

MonkongdeeP

TasaneeyapanT

2010 An algorithm for tuberculosis screening and diagnosis in people with HIV. N Engl J Med 362 707 716

21. DayJH

CharalambousS

FieldingKL

HayesRJ

ChurchyardGJ

2006 Screening for tuberculosis prior to isoniazid preventive therapy among HIV-infected gold miners in South Africa. Int J Tuberc Lung Dis 10 523 529

22. CorbettEL

BandasonT

CheungYB

MunyatiS

Godfrey-FaussettP

2007 Epidemiology of tuberculosis in a high HIV prevalence population provided with enhanced diagnosis of symptomatic disease. PLoS Med 4 e22 doi:10.1371/journal.pmed.0040022

23. LewisJJ

CharalambousS

DayJH

FieldingKL

GrantAD

2009 HIV infection does not affect active case finding of tuberculosis in South African gold miners. Am J Respir Crit Care Med 180 1271 1278

24. ShahS

DemissieM

LambertL

AhmedJ

LeulsegedS

2009 Intensified tuberculosis case finding among HIV-Infected persons from a voluntary counseling and testing center in Addis Ababa, Ethiopia. J Acquir Immune Defic Syndr 50 537 545

25. KimerlingME

SchuchterJ

ChantholE

KunthyT

StuerF

2002 Prevalence of pulmonary tuberculosis among HIV-infected persons in a home care program in Phnom Penh, Cambodia. Int J Tuberc Lung Dis 6 988 994

26. LawnS

EdwardsD

KranzerK

VogtM

BekkerL

2009 Urine lipoarabinomannan assay for tuberculosis screening prior to antiretroviral therapy: diagnostic yield and association with immune reconstitution disease. AIDS 23 1875 1880

27. WoodR

MiddelkoopK

MyerL

GrantAD

WhitelawA

2007 Undiagnosed tuberculosis in a community with high HIV prevalence: implications for tuberculosis control. Am J Respir Crit Care Med 175 87 93

28. MohammedA

EhrlichR

WoodR

CilliersF

MaartensG

2004 Screening for tuberculosis in adults with advanced HIV infection prior to preventive therapy. Int J Tuberc Lung Dis 8 792 795

29. ChhengP

TamhaneA

NatpratanC

TanV

LayV

2008 Pulmonary tuberculosis among patients visiting a voluntary confidential counseling and testing center, Cambodia. Int J Tuberc Lung Dis 12 54 62

30. BassettIV

WangB

ChettyS

GiddyJ

LosinaE

2010 Intensive tuberculosis screening for HIV-infected patients starting antiretroviral therapy in Durban, South Africa. Clin Infect Dis 51 823 829

31. CrucianiM

ScarparoC

MalenaM

BoscoO

SerpelloniG

2004 Meta-analysis of BACTEC MGIT 960 and BACTEC 460 TB, with or without solid media, for detection of mycobacteria. J Clin Microbiol 42 2321 2325

32. HarbordRM

DeeksJJ

EggerM

WhitingP

SterneJA

2007 A unification of models for meta-analysis of diagnostic accuracy studies. Biostatistics 8 239 251

33. ReitsmaJB

GlasAS

RutjesAW

ScholtenRJ

BossuytPM

2005 Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol 58 982 990

34. GrimesDA

SchulzKF

2005 Refining clinical diagnosis with likelihood ratios. Lancet 365 1500 1505

35. ReillyB

EvansA

2006 Translating clinical research into clinical practice: impact of using prediction rules to make decisions. An Intern Med 144 210 212

36. WHO 2004 Compendium of indicators for monitoring and evaluating national tuberculosis programs. WHO/HTM/TB/2004.344. Geneva: WHO

37. MosimaneotsileB

TalbotEA

MoetiTL

HoneNM

MoalosiG

2003 Value of chest radiography in a tuberculosis prevention programme for HIV-infected people, Botswana. Lancet 362 1551 1552

38. SamandariTAT

ArwadyA

YoonJ

NyirendaS

2007 Asymptomatic pulmonary TB among HIV-infected adults screened for the Botswana isoniazid preventive therapy clinical trial, 2004-2006 [Abstract 862]. In: Proceedings of the 14th Conference on Retroviruses and Opportunistic Infections; 25-28 February 2007; Los Angeles, California, United States

39. KranzerK

HoubenRM

GlynnJR

BekkerLG

WoodR

2010 Yield of HIV-associated tuberculosis during intensified case finding in resource-limited settings: a systematic review and meta-analysis. Lancet Infect Dis 10 93 102

40. LawnSD

WoodR

De CockKM

KranzerK

LewisJJ

2010 Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resources. Lancet Infect Dis 10 489 498

41. BanerjiD

AndersenS

1963 A sociological study of awareness of symptoms among persons with pulmonary tuberculosis. Bull World Health Organ 29 665 683

42. WHO 2007 Improving the diagnosis and treatment of smear-negative pulmonary and extrapulmonary tuberculosis among adults and adolescents: recommendations for HIV-prevalent and resource-constrained settings. WHO/HTM/TB/2007.376 WHO/HIV/2007.01. Geneva: WHO

Štítky
Interné lekárstvo

Článok vyšiel v časopise

PLOS Medicine


2011 Číslo 1
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#